UE2316
UE2316 is an orally active and specific 11βHSD1 inhibitor. UE2316 significantly improves glucose tolerance and insulin sensitivity in uremic rats. UE2316 also exacerbates hepatic fibrosis in mice. UE2316 can be used in the research of diseases such as hepatic fibrosis, uremia and diabetes mellitus.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1274933-58-2
- 分子式: C19H17ClFN3OS
- 分子量:389.87
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
UE2316 (10 μM; 8 days) reverses the inhibitory effect of glucocorticoids on the expression of pro-fibrotic genes (Acta2, Col1a1) in primary hepatic stellate cell (HSC) culture systems derived from C57Bl/6J mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HSCs
-
Concentration:10 μM
-
Incubation Time:8 days
-
Result:Increased the mRNA levels of Acta2 and Col1a1.
UE2316 (20 mg/kg; s.c. osmotic pump; 2 weeks) improves glucose tolerance and insulin sensitivity in adenine (HY-B0152)-induced uremic rats[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar (male, 7 weeks old, Adenine (HY-B0152)-induced uremia)[1]
-
Dosage:20 mg/kg
-
Administration:s.c. minipump; daily; 2 weeks
-
Result:Significantly improved glucose tolerance and insulin sensitivity in adenine-fed rats.
Showed no effect on renal failure parameters.
-
Animal Model:C57Bl/6J (male, adult, carbon tetrachloride-induced)[2]
-
Dosage:0.15% (in chow diet)
-
Administration:oral; 12-weeks
-
Result:Exacerbates liver fibrosis.
Delayed scar resolution.
Reduced plasma ALT and AST levels.
化学情報
-
CAS 番号 1274933-58-2
-
分子量 389.87
-
分子式 C19H17ClFN3OS
-
SMILES
O=C(C1=CSC(=C1)C=2C=NNC2)N3CCC(F)(C=4C=CC=CC4Cl)CC3
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Zou X, et al. 11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis. Hepatology. 2018;67(6):2167-2181. [Content Brief]
[2]. Chapagain A, et al. Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia. Proc Natl Acad Sci U S A. 2014;111(10):3817-3822. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)